The Cassi II Rotational Core Biopsy System reportedly is the first large core biopsy device on the market that is fully automated, self contained, hand-held and disposable. No capital equipment is required, saving both the expense and associated set-up time to perform a biopsy procedure.
The Visica Treatment System uses cryoablation as a minimally invasive means to surround and destroy a fibroadenoma in a lethal ball of ice. Throughout the procedure, ultrasound visualization provides accurate guidance, added safety and confirmation that the iceball has fully engulfed the fibroadenoma. This safe and effective procedure can be performed in an office in about 30 minutes, using local anesthesia. This "in- office cryoablation technology" destroys fibroadenomas as an alternative to surgical excision.

Related Content

News | Women's Health

March 4, 2022 — The WTA and Hologic today jointly announced a landmark partnership introducing Hologic as the global ...

Time March 04, 2022
arrow
News | Breast Biopsy Systems

July 7, 2021 — GE Healthcare announced the installation of Serena Bright in five hospitals and radiology centers around ...

Time July 07, 2021
arrow
News | Brachytherapy Systems

October 26, 2020 — iCAD, Inc. announced the Company will showcase the expanded platform for the Xoft Axxent Electronic ...

Time October 26, 2020
arrow
News | Brachytherapy Systems, Women's Healthcare

September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the ...

Time September 08, 2020
arrow
News | Breast Biopsy Systems

August 28, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...

Time August 28, 2020
arrow
News | Breast Imaging

November 26, 2019 — Unifi Workspace, a new comprehensive breast diagnostic reading solution from Hologic, will launch at ...

Time November 26, 2019
arrow
Feature | Breast Biopsy Systems | By Harriet Borofsky, M.D.

The current body of research supporting digital breast tomosynthesis (DBT or 3-D mammography) is now overwhelming, with ...

Time October 17, 2019
arrow
Technology | Breast Biopsy Systems

Fujifilm Medical Systems U.S.A. Inc. recently expanded its breast imaging solutions with the launch of its Tomosynthesis Biopsy option for the Aspire Cristalle mammography system. This new option uses tomosynthesis guidance to calculate 3-D coordinates of a suspicious lesion in the breast, in addition to the traditional stereotactic method. This allows radiologists to accurately complete biopsy of suspicious areas to conduct a pathological examination and inform the diagnosis and care plan. Clinicians will now be able to enhance diagnostic care for patients by using Tomosynthesis Biopsy to target a lesion previously undetectable on images from full field digital mammography (FFDM) alone.

Time July 24, 2019
arrow
Technology | Breast Biopsy Systems

Hologic Inc. announced global commercial availability of the Trident HD specimen radiography system. The next-generation solution delivers enhanced image quality, improved workflow and instant sample verification during breast-conserving surgeries and stereotactic breast biopsies.

Time April 26, 2019
arrow
Feature | Breast Imaging | By Greg Freiherr

Wires have traditionally been placed prior to lumpectomy to mark cancerous tissues in the breast. Wire-free localizers ...

Time April 24, 2019
arrow
Subscribe Now